DDL and Gateway Analytical Announce Joint Agreement

Companies to collaborate on offering complementary services including device testing, stability storage and analytical (extractable leachable studies) testing to the life sciences industry

This content was submitted directly to this website by the supplier.

DDL, Inc. and Gateway Analytical announced they have entered into a joint agreement to offer complementary testing services to the pharmaceutical, biotech and medical device industries.

DDL, a full-service testing lab that specializes in package, product and materials testing to the medical device industry, will provide mechanical testing of devices, ASTM testing method services, and stability sampling and storage as part of the agreement.Gateway Analytical, a contract analytical laboratory offering standard and novel analytical testing techniques to the pharmaceutical, materials science and forensics industries,will provide foreign particulate characterization, materials characterization, and extractable leachable studies.

“DDL is excited to be working with Gateway, an established expert in the field of particulate analysis and identification,” said Corey Hensel, General Manager with DDL. “This agreement allows our mutual customers to better leverage the expertise both companies offer to help life science companies bring their products to market.”

“Gateway Analytical is pleased to be in collaboration with DDL,” says David Exline, President at Gateway Analytical. “This agreement allows us to offer our clients a more comprehensive range of solutions and expertise in both common and specialized areas. We see excellent benefits in achieving mutual business objectives by working with DDL.”

DDL and Gateway will be jointly attending the 7thEdition PFS & Injectables Summit being held September 26-28 in San Diego, CA. Please visit www.testedandproven.com for more information on DDL’s testing services and http://www.gatewayanalytical.com/ for more information on Gateway Analytical’s services.

More in Home